Global Female Sexual Dysfunction Treatment Market Size study & Forecast, 2022-2029

by Type( Arousal Disorder, Penetration Disorder, Female Orgasmic Disorder) by Therapy( Estrogen Therapy, Androgen Therapy and Others), by Age( 25 Years, 25-40 Years and Above 40 Years.), and Regional Analysis,

Published	Pages	Publisher	Report code
Mar 2023	200	Bizwit Research	ASDR-617687

Published: Mar 2023 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-617687

Apricus Biosciences
Inc
GlaxoSmithKline
plc.
Pfizer Inc.
AMAG Pharmaceuticals
Merck & Co. Inc.
Cipla Inc.
Duchesnay Inc.
Sprout Pharmaceuticals Inc.
Novo Nordisk AS,
Strategic Science and Technologies LLC

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

Published: May, 2022 | Report code: ASDR-601516